Class information for:
Level 1: PROGRAMMED VENTRICULAR STIMULATION//ENCAINIDE//PROGRAMMED STIMULATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1730 2435 30.4 54%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
893 10679 AMIODARONE//DESETHYLAMIODARONE//PROPAFENONE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROGRAMMED VENTRICULAR STIMULATION Author keyword 7 30% 1% 20
2 ENCAINIDE Author keyword 4 36% 0% 8
3 PROGRAMMED STIMULATION Author keyword 4 26% 0% 12
4 ELECTROPHYSIOLOGICAL TESTING Author keyword 3 28% 0% 10
5 ANTIARRHYTHMIC THERAPY Author keyword 2 15% 1% 15
6 PROGRAMMED ELECTRICAL STIMULATION Author keyword 2 17% 0% 11
7 VENTRICULAR EFFECTIVE REFRACTORY PERIOD Author keyword 1 38% 0% 3
8 COMBINATION OF DRUGS Author keyword 1 50% 0% 2
9 ELECTROPHYSIOLOGY PROTOCOLS Author keyword 1 100% 0% 2
10 SERIAL DRUG TESTING Author keyword 1 50% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PROGRAMMED VENTRICULAR STIMULATION 7 30% 1% 20 Search PROGRAMMED+VENTRICULAR+STIMULATION Search PROGRAMMED+VENTRICULAR+STIMULATION
2 ENCAINIDE 4 36% 0% 8 Search ENCAINIDE Search ENCAINIDE
3 PROGRAMMED STIMULATION 4 26% 0% 12 Search PROGRAMMED+STIMULATION Search PROGRAMMED+STIMULATION
4 ELECTROPHYSIOLOGICAL TESTING 3 28% 0% 10 Search ELECTROPHYSIOLOGICAL+TESTING Search ELECTROPHYSIOLOGICAL+TESTING
5 ANTIARRHYTHMIC THERAPY 2 15% 1% 15 Search ANTIARRHYTHMIC+THERAPY Search ANTIARRHYTHMIC+THERAPY
6 PROGRAMMED ELECTRICAL STIMULATION 2 17% 0% 11 Search PROGRAMMED+ELECTRICAL+STIMULATION Search PROGRAMMED+ELECTRICAL+STIMULATION
7 VENTRICULAR EFFECTIVE REFRACTORY PERIOD 1 38% 0% 3 Search VENTRICULAR+EFFECTIVE+REFRACTORY+PERIOD Search VENTRICULAR+EFFECTIVE+REFRACTORY+PERIOD
8 COMBINATION OF DRUGS 1 50% 0% 2 Search COMBINATION+OF+DRUGS Search COMBINATION+OF+DRUGS
9 ELECTROPHYSIOLOGY PROTOCOLS 1 100% 0% 2 Search ELECTROPHYSIOLOGY+PROTOCOLS Search ELECTROPHYSIOLOGY+PROTOCOLS
10 SERIAL DRUG TESTING 1 50% 0% 2 Search SERIAL+DRUG+TESTING Search SERIAL+DRUG+TESTING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TACHYCARDIA INDUCTION 23 76% 1% 16
2 TRIPLE EXTRASTIMULI 17 72% 1% 13
3 PROGRAMMED ELECTRICAL STIMULATION 16 26% 2% 55
4 TACHYARRHYTHMIAS 15 10% 6% 135
5 TO DAY REPRODUCIBILITY 15 73% 0% 11
6 ANTIARRHYTHMIC THERAPY 11 31% 1% 30
7 SPONTANEOUS VARIABILITY 11 45% 1% 18
8 PROGRAMMED STIMULATION 10 23% 2% 37
9 LATE HOSPITAL PHASE 8 40% 1% 16
10 ORAL PROCAINAMIDE 8 100% 0% 5

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
SUDDEN-DEATH IN IDIOPATHIC DILATED CARDIOMYOPATHY 1992 83 74 45%
Exercise test-induced arrhythmias 2005 11 40 53%
Influence of holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial 1996 6 25 92%
SUDDEN-DEATH IN IDIOPATHIC DILATED CARDIOMYOPATHY - ROLE OF VENTRICULAR ARRHYTHMIAS 1993 18 25 72%
Supraventricular tachycardia - Cardiac, non-cardiac and arrhythmogenic risks of antiarrhythmic agents 1998 2 3 100%
Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone 1998 5 14 57%
PREDICTING AND PREVENTING SUDDEN-DEATH FROM CARDIAC CAUSES 1994 33 86 40%
Randomized clinical trial of the noninvasive and invasive approaches to drug therapy for ventricular tachycardia: Long-term follow-up of the calgary trial 1996 6 20 80%
A summary and assessment of the findings and conclusions of the ESVEM trial 1996 9 26 58%
A CONSENSUS REPORT ON ANTIARRHYTHMIC DRUG-USE 1994 31 99 36%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CHAIR HOSP THER Y 2 1 50% 0.0% 1
2 DIAG TREATMENT ATHEROSCLEROSIS LIPID DIS 1 50% 0.0% 1
3 SECT CARDIOL 111A 1 50% 0.0% 1
4 ARRHYTHMIA OFF 0 33% 0.0% 1
5 CARDIOL K14 0 33% 0.0% 1
6 RAFFLES HEART 0 20% 0.0% 1
7 GEOG STUDIES REG PLANNING 0 17% 0.0% 1
8 NEW ENGLAND CARDIAC ARRHYTHMIA SERV 0 17% 0.0% 1
9 BIOL PHYS EDUC 0 14% 0.0% 1
10 CARDIOLSECT ELE OPHYSIOL 0 14% 0.0% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000178682 MORICIZINE//ETHMOZINE//TIRACIZINE
2 0.0000174790 FLECAINIDE//BIDISOMIDE//AH 1058
3 0.0000169676 MEXILETINE//MEXILETINE HYDROCHLORIDE//CLIN NEW DRUGS THER EUT
4 0.0000154420 CIBENZOLINE//DISOPYRAMIDE//MONO N DEALKYLDISOPYRAMIDE
5 0.0000150280 PALPITATIONS//HEARTSCAN//EVENT RECORDER
6 0.0000142690 N ACETYLPROCAINAMIDE//ACECAINIDE//DRUG LIBRARY
7 0.0000134833 LATE POTENTIALS//VENTRICULAR LATE POTENTIALS//SIGNAL AVERAGED ECG
8 0.0000133721 PROPAFENONE//5 HYDROXYPROPAFENONE//DIPRAFENONE
9 0.0000105389 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR//IMPLANTABLE CARDIOVERTER DEFIBRILLATORS//ICD
10 0.0000104154 DOFETILIDE//MS 551//SOTALOL